Medicine heals the sick and saves lives. But the development of new medical products is both cost-intensive and time-consuming. Before a new treatment is allowed on the market, complex criteria need to be met, which involves an endless array of tests. This has far-reaching consequences for the research and development of new medications in Germany. The U.S. is well ahead of Europe here.
The cooperation between hospitals, the biotechnology industry and pharmaceutical companies is regulated differently than in Europe. Is that why they are quicker to bring innovative developments onto the market?
In Focus documentaries and reports cover business and science, culture and education, historical and present day events as well as sports and leisure. This wide variety of topics is investigated in depth and presented in an informative format, making for captivating television, courtesy of Germany's Deutsche Welle news network.
Cancel Response
Post Response